Drawing for MACKLIN

USPTO serial 98862801

MACKLIN

Reviewed by CopyMark Law Group

Reg. 8307054Status 700Registered
Filing date
Status date
Registration date
Jun 16, 2026
Examiner
TARASCIO, MAUREEN J
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with MACKLIN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Yue (Robert) Xu

Yue (Robert) Xu Apex Attorneys at Law, LLP160 Alamo Plaza # 942ALAMO, CA 94507United States

Goods and services

ClassDescriptionStatusFirst use
001Aliphatics; Organosiloxane; Polyurethane; Silanes; Active chemical ingredients for use in the manufacture of pharmaceuticals for treating inflammation, allergies, oxidation, cancer metastasis, cardiovascular diseases; Aldehydes and ketones; Ammonium salts; Aromatic hydrocarbons; Biochemical preparations for scientific purposes; Biochemical reagents used for non-medical purposes; Biochemicals for in vitro and in vivo scientific use; Boric in the form of acid, esters; Catalytic agents; Cell culture media for scientific and research use; Chemical preparations in the nature of ion-exchange resins; Chemical reagents for non-medical purposes; Chemical substances for analyses in laboratories, other than for medical or veterinary purposes; Chemicals and unprocessed plastics, namely, polymers for electronic materials; Chemicals for use in connection with solar cells; Chemicals for use in the biochemical and chemical industry; Chromatography chemicals; Dendrimer-based polymers for use in the manufacture of capsules for pharmaceuticals; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; Diagnostic reagents for scientific or research use; Diagnostic reagents for scientific use; Enzymes for scientific and research purposes; Fluorescent dye for scientific or research use; Halides and halogen acid salts; Heterocyclic compounds; Metal chlorides; Metallic oxides; Non-metallic oxides; Organic acid salts; Organic halogenides; Reagents for research purposes; Reagents for scientific and research use; Reagents for scientific or medical research use; Surface active compounds for general use in the industrial arts, namely, as wetting, spreading, emulsifying, dispersing and penetrating agents; Tea extracts for use in the manufacture of pharmaceuticals; Unprocessed polymer resins used in the manufacture of resin or fiber compositesACTIVENov 1, 2025

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 16, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jun 16, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 27, 2026SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
May 27, 2026CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
May 5, 2026SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Dec 17, 2025IUAFUSE AMENDMENT FILED—
Dec 17, 2025EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Dec 15, 2025EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Dec 15, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 15, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 15, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 12, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 17, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 17, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 11, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 14, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 14, 2025XAECEXAMINER'S AMENDMENT ENTERED—
May 14, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 14, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
May 14, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
May 14, 2025DOCKASSIGNED TO EXAMINER—
May 9, 2025MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
May 9, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 24, 2024TAEATEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED—
Nov 24, 2024PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Nov 20, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance